首页> 外文OA文献 >P2-319: Taxotere as salvage chemotherapy in Chinese patients with advanced NSCLC who have failed or relapsed after the gefitinib target treatment

【2h】

P2-319: Taxotere as salvage chemotherapy in Chinese patients with advanced NSCLC who have failed or relapsed after the gefitinib target treatment

机译：P2-319：在吉非替尼靶向治疗后失败或复发的中国晚期NSCLC患者中，紫杉醇作为挽救性化疗药物

页面导航

著录项
相似文献
相关主题

著录项

作者
Wu Yi-Long; Yang Jin-Ji; Huang Yu-Juang; Liao Ri-Qiang; Zhou Qin; Huang Yi-Sheng; Xu Chong-Rui;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Weekly short infusion of taxotere at a 4 week cycle in Chinese patients with advanced NSCLC who have failed or relapsed after the frontline platinum-based non-taxane chemotherapy--a Phase II trial. [J] . Tsao TC, Chen CH, Chang JW, Japanese journal of clinical oncology. . 2006 ,第2期

机译：第二阶段试验是在一线铂类非紫杉烷一线化疗后失败或复发的中国晚期NSCLC患者中，以4周为周期每周一次短暂注入紫杉醇。
2. Weekly Short Infusion of Taxotere at a 4 Week Cycle in Chinese Patients with Advanced NSCLC Who Have Failed or Relapsed after the Frontline Platinum-based Non-Taxane Chemotherapy—A Phase II Trial [J] . Thomas C. Y. Tsao, Chih-Hung Chen, John W. C. Chang, Japanese Journal of Clinical Oncology . 2006 ,第2期

机译：中国一线铂类非Ta烷化疗一线治疗后失败或复发的晚期NSCLC中国患者，以4周为周期每周一次短暂注入紫杉醇（II期试验）
3. PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH SECOND LINE ERLOTINIB/GEFITINIB WHO FAILED TO PREVIOUS CHEMOTHERAPY [J] . Madolangan Jamaluddin, Hudoyo Ahmad, Andarini Sita Respirology : . 2015 ,第Suppla3期

机译：曾接受过第二次化疗的厄洛替尼/吉非替尼二线治疗的晚期非小细胞肺癌（NSCLC）患者的无进展生存期（PFS）
4. Radio-Thermo-chemotherapy Comprehensive Treatment Advanced NSCLC [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：放化疗综合治疗晚期非小细胞肺癌
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy [O] . Francesco Sclafani, Gina Brown, David Cunningham, 2017

机译：无法对标准新辅助放化疗进行反应的局部晚期直肠癌患者的全身化学疗法作为挽救性治疗
7. Apatinib Alone or Combined with Radiation Therapy As a Salvage Treatment in Advanced Non-Small Cell Lung Cancer Failed from Two or More Lines of Prior Chemotherapy or Molecular Targeted Therapy [O] . T. Li, J. Lv, Q. Wang, 2018

机译：单独的Apatinib或与放射治疗结合作为晚期非小细胞肺癌的救人治疗失败，从两种或更多种以前化学疗法或分子靶向治疗

P2-319: Taxotere as salvage chemotherapy in Chinese patients with advanced NSCLC who have failed or relapsed after the gefitinib target treatment

著录项

相似文献

相关主题

期刊订阅